NewAmsterdam Pharma Company NV Ordinary Shares

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$14.06-$42
Market Cap
$4.4B
Shares Short
6M

Financials

See more
Revenue (12 Mos)
$35.2M
Revenue Growth (YoY)
-98.8%
Gross Profit (12 Mos)
$35.2M
Diluted EPS
-$2.04

News

See more

Yahoo Finance • 8 days ago

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in December

Yahoo Finance • 14 days ago

Biotech Stock Gets Booted in Latest Fund Update

Yahoo Finance • 19 days ago

Stanley Druckenmiller's Strategic Moves: Exiting Philip Morris International Inc with a -3. ...

Yahoo Finance • 26 days ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

About

CEO
Dr. Michael Harvey Davidson FACC, Facp., M.D.
Address
Gooimeer 2-35, Naarden, Netherlands, 1411 DC
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
68